Amneal (NYSE:AMRX) is building one of the most dynamic pharmaceutical companies in our industry. Today’s healthcare environment requires new ideas. While staying true to our reputation for quality, service and value in pharmaceuticals, we are challenging ourselves, our playbook and the status quo. We are uniting people, passion and products to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges. We are Amneal and “We make healthy possible.” Learn more about how we’re making a difference in generics, brands and biosimilars at Amneal.com.
Location: United States, New Jersey
Employees: 5001-10000
Founded date: 2002
Investors 1
| Date | Name | Website |
| - | Tarsadia I... | tarsadia.c... |
Mentions in press and media 15
| Date | Title | Description |
| 29.06.2026 | Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities | Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the FDA’s PreCheck pilot program, CNBC has learned. The FDA PreCheck program is designed t... |
| 26.06.2026 | Estrogen patches are hard to find, and it may not be resolved any time soon | Estrogen patches are hard to find as demand for menopause support skyrockets. Hormone replacement therapy has been becoming more popular as women share stories on social media and after the FDA removed a black box warning on the medications... |
| 15.10.2025 | Industry veterans join Lifesciences and fashion-tech startups | MetaLead Therapeutics, a spinoff of the University of Zurich, has developed a novel metal-binding peptide platform to create best-in-class therapeutics that target pathological metals, restore healthy balance, or deliver therapeutic counte... |
| 04.09.2025 | Stock futures are little changed ahead of August jobs report: Live updates | Stock futures were mixed Friday as investors prepare for a key nonfarm payrolls report. Futures tied to the Dow Jones Industrial Average inched down 31 points, or 0.1%, while S&P 500 futures rose 0.2%. Nasdaq-100 futures gained 0.5%. Th... |
| 19.04.2025 | Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter | COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product... |
| 18.04.2025 | Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter | COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product... |
| 19.10.2024 | Gland Pharma Welcomes New Leadership Amidst Industry Shifts | Gland Pharma is turning a new page. The company has appointed Shyamakant Giri as its new Chief Executive Officer, effective January 15, 2025. This move comes at a pivotal time for the pharmaceutical industry, which is undergoing rapid chang... |
| 18.10.2024 | Shyamakant Giri is new CEO of Gland Pharma | Gland Pharma’s Board has approved the appointment of Shyamakant Giri as the new Chief Executive Officer (CEO) of the Company. Mr. Giri is expected to join the Company with effect from January 15, 2025. Giri is a business leader with over 25... |
| 21.09.2024 | The Future of Healthcare: Innovation and Collaboration at Pharmavision India 2024 | The healthcare landscape is shifting. At the forefront of this change is the 15th annual Pharmavision India conference, set to take place on September 25-26, 2024, in Ahmedabad and Hyderabad. This event is not just a gathering; it’s a cruci... |
| 18.09.2024 | Clarivate Announces 15th Annual Pharmavision India Conference Agenda | Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event LONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intellig... |
Show more